These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31617972)

  • 21. Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital.
    Gisbert JP; McNicholl AG
    Helicobacter; 2012 Apr; 17(2):160-1. PubMed ID: 22404448
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Eradication therapy for Helicobacter pylori infection: review of world trends].
    Maev IV; Kucheriavyĭ IuA; Andreev DN; Barkalova EV
    Ter Arkh; 2014; 86(3):94-9. PubMed ID: 24779078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility.
    Miyaki A; Yamaguchi K; Ida A; Miyauchi T
    Minerva Gastroenterol Dietol; 2016 Sep; 62(3):234-9. PubMed ID: 27304198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
    Puig I; Baylina M; Sánchez-Delgado J; López-Gongora S; Suarez D; García-Iglesias P; Muñoz N; Gisbert JP; Dacoll C; Cohen H; Calvet X
    J Antimicrob Chemother; 2016 Oct; 71(10):2740-53. PubMed ID: 27342548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Bismuth in the Eradication of Helicobacter pylori.
    Alkim H; Koksal AR; Boga S; Sen I; Alkim C
    Am J Ther; 2017; 24(6):e751-e757. PubMed ID: 26808355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
    Kawai T; Yamagishi T; Yagi K; Kataoka M; Kawakami K; Sofuni A; Itoi T; Sakai Y; Moriyasu F; Osaka Y; Takagi Y; Aoki T; Rimbara E; Noguchi N; Sasatsu M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S171-4. PubMed ID: 19120893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori resistance to clarithromycin in Reunion Island.
    Zemali N; Guillemot G; Jaubert J; Picot S; Thomas E; Becquart JP; Camuset G; Gérardin P; Michault A; Kwiatek S
    Med Mal Infect; 2016 Oct; 46(7):385-389. PubMed ID: 27427280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori eradication in the Swedish population.
    Doorakkers E; Lagergren J; Gajulapuri VK; Callens S; Engstrand L; Brusselaers N
    Scand J Gastroenterol; 2017; 52(6-7):678-685. PubMed ID: 28323552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.
    Lee HJ; Kim JI; Cheung DY; Kim TH; Jun EJ; Oh JH; Chung WC; Kim BW; Kim SS; Park SH; Kim JK
    J Infect Dis; 2013 Oct; 208(7):1123-30. PubMed ID: 23801607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The present status and problems of Helicobacter pylori first-line eradication therapy].
    Tokunaga K; Tanaka A; Sugano H; Takahashi S
    Nihon Rinsho; 2009 Dec; 67(12):2291-6. PubMed ID: 19999114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of packed therapy with three drugs in Helicobacter pylori eradication in Japan.
    Sasaki M; Ogasawara N; Utsumi K; Kamiya T; Kataoka H; Tanida S; Mizoshita T; Shimura T; Hirata Y; Kasugai K; Joh T
    Methods Find Exp Clin Pharmacol; 2010 May; 32(4):243-6. PubMed ID: 20508872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions.
    Martos M; Bujanda L; Salicio Y; Sarasqueta C; Ibarra B; Mendarte U; Fernández-Reyes M; Cosme A
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1380-4. PubMed ID: 25229983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
    Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based recommendations for successful Helicobacter pylori treatment.
    Wu JY; Liou JM; Graham DY
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):21-8. PubMed ID: 24410470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
    Marin AC; McNicholl AG; Gisbert JP
    Expert Opin Pharmacother; 2013 May; 14(7):843-61. PubMed ID: 23537368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
    Gisbert JP; Bermejo F; Castro-Fernández M; Pérez-Aisa A; Fernández-Bermejo M; Tomas A; Barrio J; Bory F; Almela P; Sánchez-Pobre P; Cosme A; Ortiz V; Niño P; Khorrami S; Benito LM; Carneros JA; Lamas E; Modolell I; Franco A; Ortuño J; Rodrigo L; García-Durán F; O'Callaghan E; Ponce J; Valer MP; Calvet X;
    Am J Gastroenterol; 2008 Jan; 103(1):71-6. PubMed ID: 17764498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.